Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Salvia BioElectronics

Salvia BioElectronics is a medical device company that develops neuromodulation therapies for migraines
2017
Nov-50
11-50
North Brabant, The Netherlands

Innovation

Industry Problem

People with chronic migraine or cluster headache may not respond to medicines and need a less invasive long-term therapy.

R&D Focus

Implantable neuromodulation for migraine and cluster headache.

Innovative Solution

MySalvia uses a thin implanted stimulator to target nerves involved in headache disorders through personalized stimulation.

Investment Funding

Last Funding Stage

Grant

Total Funding Amount

$34.4M

Last Funding Date

2/28/2024

Startup Stage

Growth Stage

Lead Investors

MedTech Innovator, European Innovation Council Fund, Dolby Family Ventures, Inkef, Panakes Partners

People

Founders

CEO

About

Salvia BioElectronics is a medical device company that develops neuromodulation therapies for migraines

Products

Product

MySalvia Therapy for chronic migraine.

Star Product

MySalvia, because it is the lead clinical program and planned first commercial therapy.

Demo Product or Complete Product?

Clinical-stage device being evaluated in the RECLAIM study; not yet commercially authorized.

Future Plan

Market Expansion

Preparing regulatory submissions and commercial launch in the United States, Europe and Australia.

Investment Funding

$60 million Series B announced in May 2025 to complete clinical development and prepare commercialization.

M&A and Collabs

Collab

RECLAIM clinical centers: multicenter, double-blind, sham-controlled migraine study.

Collab

European Innovation Council: financing support for product and indication development.

Something missing or incorrect on this page? Help us enrich this information